BTIG analyst Jeet Mukherjee raised the price target on Monopar Therapeutics (NASDAQ: MNPR) to $104.00 (from $87.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE